Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Oral Probiotics (Streptococcus Salivarius K12) on Biofilm, Salivation, and Secretory Immunoglobulin A Salivary Level: a Pilot Randomized Clinical Trial

NCT05039320 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.

NCT NCT05039320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05039320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Oral Probiotics (Streptococcus Salivarius K12) on Biofilm, Salivation, and Secretory Immunoglobulin A Salivary Level: a Pilot Randomized Clinical Trial
Lead sponsor
I.M. Sechenov First Moscow State Medical University
Phase
Not applicable
Overall status
Completed
Start date
September 2, 2021
Completion date
November 4, 2021
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral disease